| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |